Folic acid b6
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Folic Acid and Vitamin B6 on Health Outcomes
Cardiovascular Health and Homocysteine Levels
Homocysteine Reduction and Cardiovascular Events
Research has consistently shown that elevated homocysteine levels are associated with an increased risk of cardiovascular diseases (CVD). Supplementation with folic acid and vitamin B6 has been found to significantly reduce plasma homocysteine levels by approximately 25% to 30% 134. The Heart Outcomes Prevention Evaluation (HOPE)-2 trial, one of the largest studies in this area, is evaluating whether long-term therapy with folic acid and vitamins B6 and B12 can reduce the risk of major cardiovascular events in high-risk patients . However, while homocysteine levels were effectively lowered, the clinical benefits in terms of reducing cardiovascular events remain inconclusive 49.
Subclinical Atherosclerosis
In a study involving healthy siblings of patients with premature atherothrombotic disease, folic acid and vitamin B6 supplementation was associated with a significant reduction in fasting and postmethionine homocysteine concentrations. This treatment also decreased the rate of abnormal exercise electrocardiography tests, suggesting a potential reduction in the risk of atherosclerotic coronary events .
Inflammation and Endothelial Dysfunction
Despite the reduction in homocysteine levels, long-term combined treatment with folic acid, vitamin B6, and vitamin B12 did not alter major biomarkers of vascular inflammation or endothelial dysfunction in women at increased risk of cardiovascular disease . This finding aligns with the lack of observed clinical cardiovascular benefits in the trial.
Cognitive Function and Mental Health
Cognitive Decline in Older Adults
A study investigating the effects of folic acid, vitamin B6, and B12 supplementation on cognitive function in older men found no significant improvement in cognitive performance or reduction in the risk of cognitive impairment and dementia over an 8-year follow-up period . This suggests that while these vitamins can lower homocysteine levels, they do not necessarily translate into cognitive benefits for older adults.
First-Episode Psychosis
In patients with first-episode psychosis, supplementation with folic acid, vitamin B6, and B12 was found to lower homocysteine levels but did not confer significant advantages over placebo in improving overall cognition or symptomatology. However, there were specific cognitive benefits observed in females, particularly in the domains of speed of processing and attention/vigilance .
Maternal and Infant Health
Nutritional Status of Lactating Women
A study on low socioeconomic lactating women showed that supplementation with folic acid, vitamin B6, and B12 significantly increased the concentrations of these vitamins in breast milk. This suggests that dietary changes or supplements may be necessary to maintain recommended levels of these vitamins in breast milk, especially in populations with consistently low dietary intake .
Meta-Analyses and Systematic Reviews
Cardio-Cerebrovascular Diseases
Meta-analyses have shown that combined supplementation of folic acid, vitamin B6, and B12 does not significantly affect the incidence of cardiovascular disease events or myocardial infarction. However, it can reduce the risk of stroke by 14% and lower homocysteine levels . Another meta-analysis indicated that folic acid supplementation, particularly when combined with moderate doses of vitamin B6, may reduce the risk of coronary revascularization .
Conclusion
While folic acid and vitamin B6 supplementation effectively lower homocysteine levels, the clinical benefits in terms of cardiovascular health, cognitive function, and other health outcomes are mixed. The evidence suggests potential benefits in specific populations and conditions, but further research is needed to fully understand the implications and optimize supplementation strategies.
Sources and full results
Most relevant research papers on this topic